Banner

Neurotech narrows: French research firm to focus on eye technology

Article

Evry, France-Neurotech will refocus its efforts on ophthalmic technologies, halting research and development activities in the fields of neuroscience and cell therapy.

Related Videos
Related Content

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

October 1st 2023
© 2023 MJH Life Sciences

All rights reserved.